These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6109057)

  • 21. [Comparative studies of L- as well as DL-oxyfedrine in healthy people and patients with chronic ischemic heart diseases].
    Teichmann W; Lukesch KH; Rikirsch P; Schäbitz J; Schmidt GA; Vogel HC; Sziegoleit W; Enke H
    Z Arztl Fortbild (Jena); 1976 May; 70(10):554-9. PubMed ID: 782052
    [No Abstract]   [Full Text] [Related]  

  • 22. Possible mechanisms of action of oxyfedrine as an antianginal drug.
    Parratt JR; Mackenzie JE
    Br J Clin Pharmacol; 1981 Mar; 11(3):307-8. PubMed ID: 7213533
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of ildamen on the heart conduction system in ischemic heart disease patients].
    Shilov AM; Borisov VG
    Farmakol Toksikol; 1987; 50(5):34-6. PubMed ID: 2891566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular function in acute myocardial infarction before and after oxyfedrine.
    Agrawal BV; Agrawal VK; Somani PN
    J Indian Med Assoc; 1985 Jan; 83(1):11-4. PubMed ID: 4008944
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ildamen in stenocardias].
    Z Allgemeinmed; 1971 Jun; 47(17):921-5. PubMed ID: 4397205
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of antianginal agents with a beta-adrenostimulating component of their action on the ischemic myocardium].
    Kaverina NV; Chichkanov GG; Bogolepov AK; Azvolinskaia TN; Matsievskiĭ DD
    Farmakol Toksikol; 1982; 45(4):37-41. PubMed ID: 6127232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardioprotection by oxyfedrine in hereditary cardiomyopathic hamsters.
    Lossnitzer K; Konrad A; Mohr W; Jakob M; Stroman F
    Basic Res Cardiol; 1979; 74(6):675-86. PubMed ID: 548024
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical trial with oxyfedrine].
    De Soldati L; Lopez Salgado A; De Soldati A
    Prensa Med Argent; 1971 Jan; 57(48):2165-9. PubMed ID: 4933275
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effectiveness of adrenergic beta 1 receptor agonists in the correction of hemodynamics in patients with chronic cor pulmonale].
    Gavrisiuk VK; Morskaia ND; Iachnik AI; Morozova NA; Iakhnitsa TV
    Klin Med (Mosk); 1990 Jan; 68(1):60-3. PubMed ID: 2186208
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of prolonged treatment with oxyfedrine on intracellular potentials and on other features of cardiac function in rabbits and guinea-pigs.
    Polster P; Vaughan Williams EM
    Br J Pharmacol; 1973 Feb; 47(2):187-95. PubMed ID: 4146572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanism of the antianginal action of oxyfedrine].
    Chichkanov GG; Chumburidze VB
    Farmakol Toksikol; 1977; 40(3):302-6. PubMed ID: 20326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behaviour of myocardial contractility during the course of an acute infarction. Influence of coronary drugs.
    Cardioli E; Mantovani BA; D'Elia N; Martinelli M
    Arzneimittelforschung; 1977 Jul; 27(7):1493-8. PubMed ID: 578481
    [No Abstract]   [Full Text] [Related]  

  • 33. [Oxyfedrine--an anti-angor drug with beta-stimulating characteristics. Bibliographic data and clinical experimentation].
    Carlier J
    Rev Med Liege; 1970 Dec; 25(24):797-803. PubMed ID: 5502748
    [No Abstract]   [Full Text] [Related]  

  • 34. [Suppressant effect of oxyfedrine on development of anaphylaxis in experimental animals].
    Poriadin GV; Salmasi ZhM
    Biull Eksp Biol Med; 1981 Jul; 92(7):72-4. PubMed ID: 7295948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oxyfedrine in the therapy of coronary disease].
    Wallner H; Sternitzke N; Schieffer H
    ZFA (Stuttgart); 1980 Mar; 56(9):612-6. PubMed ID: 7376700
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of oxyfedrine on left ventricle asynergy analysed by cineventriculography].
    Barbosa Filho J; Lopes AS
    Arq Bras Cardiol; 1978 Oct; 31(5):349-53. PubMed ID: 747539
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug therapy of ischemic heart disease in ambulatory practice].
    Duck HJ; Trenckmann H; Fleischmann HJ; Neugebauer A; Schauer J
    Z Gesamte Inn Med; 1974 Nov; 29(22):932-6. PubMed ID: 4156817
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral oxyfedrine on left ventricular performance in patients of ischaemic heart disease.
    Puri VK; Mehrotra A; Agarwal SK; Hasan M
    J Assoc Physicians India; 1985 Apr; 33(4):269-71. PubMed ID: 4030673
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of cardiac excitation and conduction after administration of oxyfedrine. Preliminary observations].
    Franchi F; Padeletti L; Michelucci A; Brat A
    Boll Soc Ital Cardiol; 1977; 22(2):151-7. PubMed ID: 618199
    [No Abstract]   [Full Text] [Related]  

  • 40. Oxyfedrine and cardiac inotropism in coronary artery disease.
    Krishnaswami S; Sathyamurthy I; Mao R; Padmakumar P
    Indian Heart J; 1984; 36(3):161-5. PubMed ID: 6490047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.